Sort
130,381 grants matching “hiv”
HIV Infection In Vivo And In Vitro
$1,213,839Richard A Koup · Niaid Extramural Activities · Z01 · FY2007 · AI
Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents
$1,213,831Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Herpesviruses as Vaccine Vectors for AIDS
$1,213,797David M Knipe · Harvard Medical School · P01 · FY2006 · AI
Effects of IL-6 blockade in treated HIV infection
$1,213,749Michael Marcel Lederman · Case Western Reserve University · U01 · FY2017 · AI
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
$1,213,726Shruti H Mehta · Johns Hopkins University · R01 · FY2017 · DA
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,213,626Jayson Hunt · Maine State Dept/Health/Human Servs · U62 · FY2012 · PS
FEMALE GENITAL TRACT IN HIV PATHOGENESIS
$1,213,570Rush University Medical Center · P01 · FY2002 · HD
CTN-0121: Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders among Hospitalized Patients
$1,213,304Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2021 · DA
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART
$1,213,292Ronald J. Ellis · University Of California, San Diego · R01 · FY2010 · MH
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
$1,213,216Donald Bruce Edwards · Texas Biomedical Research Institute · U19 · FY2019 · AI
Prevention of Substance Use in At-risk Students: A Family-centered Web Program
$1,213,204Elizabeth A Stormshak · University Of Oregon · R01 · FY2021 · DA
Effects of Medication for Opioid Use Disorder on Microglial Activation and Neurocognition in People Living with HIV
$1,213,037Shelli Farhadian · Yale University · R01 · FY2024 · DA
PS04-012, HIV PREVENTION PROJECTS
$1,212,992Sandra Klocke · Nebraska State Dept Of Health · U62 · FY2009 · PS
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Lab
$1,212,889Michael Busch · Vitalant · N01 · FY2016 · HL
Addressing alcohol misuse in HIV prevention and care: The Brown University Alcohol Research Center on HIV (ARCH)
$1,212,682Christopher W. Kahler · Brown University · P01 · FY2024 · AA
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,212,678Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2015 · CA
Targeting CD180 to induce anti-KSHV response in nonhuman primates
$1,212,634Scott W Wong · Oregon Health & Science University · U01 · FY2024 · CA
Design Of Immunogens
$1,212,339Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Design Of Immunogens
$1,212,338Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Hispanic Health Disparities Research Center
$1,212,299Elias Provencio-Vasquez · University Of Texas El Paso · P20 · FY2012 · MD
PEDIATRIC AIDS CLINICAL TRIALS PROGRAM
$1,212,235Baylor College Of Medicine · U01 · FY2001 · AI
Structural Biology of HIV Assembly, Budding, and Entry
$1,212,166University Of Utah · P01 · FY2004 · GM
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus
$1,212,059Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI
Community-Based VCT: Thailand
$1,211,949David D. Celentano · Johns Hopkins University · U01 · FY2007 · MH
Mechanisms of Virus Entry into Cells and Antiviral Barriers Limiting Entry
$1,211,915Alex Compton · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA